1. Home
  2. CRWS vs JSPR Comparison

CRWS vs JSPR Comparison

Compare CRWS & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crown Crafts Inc

CRWS

Crown Crafts Inc

HOLD

Current Price

$2.77

Market Cap

29.4M

ML Signal

HOLD

Logo Jasper Therapeutics Inc.

JSPR

Jasper Therapeutics Inc.

HOLD

Current Price

$0.92

Market Cap

24.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRWS
JSPR
Founded
1957
2018
Country
United States
United States
Employees
N/A
22
Industry
Textiles
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.4M
24.4M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
CRWS
JSPR
Price
$2.77
$0.92
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$15.50
AVG Volume (30 Days)
19.4K
218.6K
Earning Date
02-11-2026
05-12-2026
Dividend Yield
11.49%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$70,270,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.51
N/A
52 Week Low
$2.35
$0.62
52 Week High
$3.38
$7.19

Technical Indicators

Market Signals
Indicator
CRWS
JSPR
Relative Strength Index (RSI) 48.21 49.02
Support Level $2.72 $0.81
Resistance Level $2.87 $1.03
Average True Range (ATR) 0.07 0.08
MACD -0.00 0.00
Stochastic Oscillator 27.79 54.61

Price Performance

Historical Comparison
CRWS
JSPR

About CRWS Crown Crafts Inc

Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Share on Social Networks: